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Abstract	  
The	  mitochondrial	  ADP/ATP	  carrier	   imports	  ADP	   from	   the	  cytosol	   and	  exports	  ATP	  
from	   the	  mitochondrial	  matrix,	  providing	  key	   steps	   in	  oxidative	  phosphorylation	   in	  
eukaryotic	   organisms.	   The	   transport	   protein	   belongs	   to	   the	   mitochondrial	   carrier	  
family,	  a	  large	  transporter	  family	  in	  the	  inner	  membrane	  of	  mitochondria.	  It	  is	  one	  of	  
the	  best	  studied	  members	  of	  the	  family	  and	  serves	  as	  a	  paradigm	  for	  the	  molecular	  
mechanism	   of	   mitochondrial	   carriers.	   Structurally,	   the	   carrier	   consists	   of	   three	  
homologous	  domains,	  each	  composed	  of	  two	  transmembrane	  α-­‐helices	  linked	  with	  a	  
loop	   and	   short	   α-­‐helix	   on	   the	   matrix	   side.	   The	   transporter	   cycles	   between	   a	  
cytoplasmic	   and	   matrix	   conformation	   in	   which	   a	   central	   substrate	   binding	   site	   is	  
alternately	  accessible	  to	  these	  compartments	  for	  binding	  of	  ADP	  or	  ATP.	  On	  both	  the	  
cytoplasmic	   and	   matrix	   side	   of	   the	   carrier	   are	   networks	   consisting	   of	   three	   salt	  
bridges	   each.	   In	   the	   cytoplasmic	   conformation,	   the	   matrix	   salt	   bridge	   network	   is	  
formed	   and	   the	   cytoplasmic	   network	   is	   disrupted,	   opening	   the	   central	   substrate	  
binding	  site	  to	  the	  intermembrane	  space	  and	  cytosol,	  whereas	  the	  converse	  occurs	  
in	   the	  matrix	   conformation.	   In	   the	   transport	   cycle,	   tighter	   substrate	  binding	   in	   the	  
intermediate	   states	   allows	   the	   interconversion	   of	   conformations	   by	   lowering	   the	  
energy	  barrier	  for	  disruption	  and	  formation	  of	  these	  networks,	  opening	  and	  closing	  
the	  carrier	  to	  either	  side	  of	  the	  membrane	  in	  an	  alternating	  way.	  The	  simultaneous	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rotation	   of	   three	   domains	   around	   a	   central	   translocation	   pathway	   constitutes	   a	  
unique	  mechanism	  among	  transport	  proteins.	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The	   mitochondrial	   ADP/ATP	   carrier	   is	   one	   of	   the	   most	   abundant	   proteins	   of	   the	  
mitochondrial	  inner	  membrane.	  The	  activity	  of	  the	  carrier	  is	  the	  first	  and	  last	  step	  in	  
oxidative	  phosphorylation	  in	  eukaryotic	  organisms,	  as	  it	  exports	  ATP,	  synthesised	  by	  
ATP	  synthase,	  out	  of	  the	  mitochondrion	  for	  use	  in	  the	  cytosol	  and	  imports	  the	  spent	  
fuel	   ADP	   back	   into	   the	  mitochondrion	   for	   ATP	   synthesis	   (Figure	   1).	   It	   is	   estimated	  
that	  our	  own	  body	  weight	  in	  ADP	  and	  ATP	  is	  transported	  every	  day	  by	  these	  carriers	  
to	   sustain	   the	   energy-­‐requiring	   processes	   in	   the	   cells	   of	   the	   human	   body.	   The	  
ADP/ATP	  carrier	  belongs	  to	  the	  mitochondrial	  carrier	  family	  of	  membrane	  proteins,	  
along	  with	  many	   other	  members	   that	   exchange	   various	  metabolites	   in	   and	   out	   of	  
mitochondria	   [1].	   As	   it	   is	   the	   most	   abundant	   carrier	   in	   the	   mitochondrial	   inner	  
membrane,	  it	  is	  one	  of	  the	  best	  studied	  members	  of	  the	  transporter	  family.	  
	  
Figure	  1.	  Mitochondrial	  ATP	  synthase	  and	  the	  ADP/ATP	  and	  phosphate	  carriers.	  
	  
The	   mitochondrial	   ADP/ATP	   carrier	   was	   discovered	   in	   the	   early	   sixties	   by	   the	  
Klingenberg	   [2,	   3]	   and	   Vignais	   [4]	   laboratories,	   following	   studies	   with	   the	   specific	  
inhibitor	   atractyloside	   (ATR),	   which	   was	   known	   to	   inhibit	   respiration	   [5].	   It	   was	  
shown	  that	  ADP/ATP	  exchange	  is	  controlled	  by	  the	  proton	  electrochemical	  gradient	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[6].	   Since	   one	   ADP,	   which	   has	   three	   negative	   charges,	   is	   exchanged	   for	   one	   ATP,	  
which	  has	  four	  negative	  charges,	  the	  equimolar	  exchange	  is	  electrophoretic,	  driven	  
by	   the	   membrane	   potential	   [7,	   8],	   which	   leads	   to	   a	   higher	   ATP	   phosphorylation	  
potential	  in	  the	  cytosol	  than	  in	  mitochondria	  [9].	  	  
Another	   major	   advance	   came	   from	   the	   discovery	   of	   a	   second	   specific	   inhibitor,	  
bongkrekic	  acid	  (BKA)	  [10].	  It	  could	  be	  demonstrated	  that	  ATR	  and	  BKA	  binding	  have	  
opposite	   effects	   on	   the	   carrier	   with	   respect	   to	   adenine	   nucleotide	   efflux	   [11].	  
Atractyloside,	  and	  the	  related	  inhibitor	  carboxyatractyloside	  (CATR)	  [12,	  13],	  bind	  to	  
the	   cytoplasmic	   conformation	   when	   the	   substrate	   binding	   site	   is	   exposed	   to	   the	  
intermembrane	   space,	   and	   via	   channels	   to	   the	   cytosol.	   In	   contrast,	   BKA,	   and	   the	  
related	   isobongkrekic	   acid	   [14],	   bind	   to	   the	   matrix	   conformation	   [11,	   15].	   These	  
observations	  gave	  rise	  to	  the	  “single	  binding	  centre	  gated	  pore	  mechanism”	  [15,	  16],	  
which	  in	  essence	  is	  an	  alternating	  access	  mechanism,	  as	  first	  proposed	  for	  the	  P-­‐type	  
ATPase	   [17].	   The	   isolation	   of	   the	   CATR-­‐bound	   complex	   in	   Triton	   X-­‐100	   [18,	   19]	  
allowed	  the	  first	  reconstitution	  experiments	  of	  a	  transport	  protein	  to	  be	  carried	  out	  
[20].	  Thus,	   the	  main	   role	  of	   the	  mitochondrial	  ADP/ATP	  carrier	   is	   to	  exchange	  one	  
ADP	   for	   one	   ATP	   molecule	   by	   an	   electrophoretic	   mechanism	   [21,	   22].	   Most	  
eukaryotic	   organisms	   have	   several	   isoforms	   to	   allow	   control	   of	   this	   important	  
function.	  Yeast,	  for	  example,	  has	  three	  isoforms	  of	  the	  ADP/ATP	  carrier,	  Aac1p	  [23],	  
Aac2p	   [24]	   and	   Aac3p	   [25].	   Aac2p	   is	   the	   principal	   ADP/ATP	   carrier	   expressed	   in	  
aerobically	   growing	   yeast,	  whereas	  Aac1p	   is	   only	   expressed	   at	   low	   levels	   [26,	   27].	  
Aac3p	   is	   expressed	   almost	   exclusively	   under	   anaerobic	   growth	   conditions	   [25],	  
where	  it	   is	  thought	  to	  transport	  ATP	  produced	  by	  glycolysis	  into	  the	  mitochondrion	  
[28].	  In	  man	  there	  are	  four	  isoforms,	  AAC1	  [29],	  AAC2	  [30,	  31],	  AAC3	  [32]	  and	  AAC4	  
[33].	   The	   AAC1	   gene	   is	   expressed	   abundantly	   in	   heart,	   skeletal	   muscle,	   lung	   and	  
testis	  and	  in	  lower	  amounts	  in	  brain,	  kidney,	  liver,	  pancreas	  and	  small	  intestine;	  the	  
AAC2	  gene	  is	  expressed	  at	  higher	  levels	  in	  lung,	  testis	  and	  small	  intestine	  and	  less	  in	  
kidney,	   liver	   and	   pancreas;	   the	   AAC3	   gene	   is	   expressed	   ubiquitously	   but	   in	   very	  
abundant	   amounts	   in	   lung	  and	   testis	   and	   strongly	   in	  pancreas	  and	   small	   intestine,	  
whereas	  AAC4	  is	  expressed	  at	  low	  levels	  in	  lung	  and	  testis	  [33].	  There	  are	  no	  obvious	  
functional	  differences	  between	  these	  isoforms,	  and	  so	  the	  main	  reason	  for	  different	  
isoforms	   might	   be	   for	   genetic	   control	   of	   the	   expression	   levels	   in	   response	   to	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different	   energetic	   requirements.	   Since	   ADP/ATP	   carriers	   are	   only	   capable	   of	  
equimolar	   exchange,	   mitochondria	   have	   ATP-­‐Mg/Pi	   carriers	   to	   alter	   the	   adenine	  
nucleotide	  pools	  in	  response	  to	  calcium	  [34-­‐36].	  
	  
Sequence,	  toplogy	  and	  structure	  
The	  complete	  amino	  acid	  sequence	  of	  the	  bovine	  ADP/ATP	  carrier	  was	  determined	  
by	  Klingenberg	  [37],	  providing	  the	  first	  sequence	  of	  a	  mitochondrial	  carrier	  protein.	  
It	   was	   noted	   by	   Saraste	   and	   Walker	   that	   there	   are	   three	   homologous	   sequence	  
repeats	   [38],	   which	   was	   found	   to	   be	   a	   defining	   feature	   of	   mitochondrial	   carriers,	  
when	  more	  sequences	  of	  mitochondrial	  carriers	  became	  available	   [39-­‐42].	  Another	  
key	   sequence	   feature	   was	   the	   signature	  motif	   of	   the	  mitochondrial	   carrier	   family	  
PX[DE]XX[KR],	  which	  can	  be	  found	  at	   the	  end	  of	   the	  odd-­‐numbered	  α-­‐helices	   in	  all	  
three	   repeats	   [43].	   A	   topology	  model	   for	   the	  mitochondrial	   carrier	   was	   proposed	  
[44],	  consisting	  of	  six	  transmembrane	  α-­‐helices	  with	  the	  N-­‐	  and	  C-­‐terminal	  ends	  both	  
in	   the	   intermembrane	   space	   [45-­‐48].	   Using	   secondary	   structure	   predictions	   and	  
analysis	  of	  conservation,	  this	  model	  was	  refined	  by	  extending	  the	  length	  of	  the	  odd-­‐
numbered	  α-­‐helices	  to	  include	  the	  signature	  motifs	  and	  by	  adding	  short	  α-­‐helices	  in	  
the	  matrix	  loops	  [49,	  50]	  (Figure	  2).	  As	  will	  be	  discussed	  later,	  there	  are	  other	  well-­‐
conserved	  symmetrical	  features	  in	  mitochondrial	  carriers	  that	  are	  important	  for	  the	  
mechanism.	  
	  
Figure	  2	  Topology	  model	  of	  the	  yeast	  ADP/ATP	  carrier	  Aac3p.	  	  
	  
The	  ADP/ATP	  carrier	  functions	  as	  a	  monomer	  
Elucidating	   the	   tertiary	   structure	   of	   a	   protein	   is	   a	   key	   step	   in	   understanding	   its	  
mechanism.	  For	  almost	  35	  years	  the	  general	  consensus	  had	  been	  that	  mitochondrial	  
ADP/ATP	  carriers	  are	  dimeric	  in	  structure	  and	  function.	  This	  view	  was	  based	  on	  data	  
from	   inhibitor	  binding	   studies	   [18,	  51],	   small-­‐angle	  neutron	  scattering	   [52],	   freeze-­‐
fracture	   electron	   microscopy	   [53],	   size	   exclusion	   chromatography	   [54],	   analytical	  
ultracentrifugation	   [54],	   blue	   native	   gel	   electrophoresis	   [55-­‐58],	   cross-­‐linking	  
experiments	  [59-­‐61],	  and	  tandem-­‐fusions	  of	  active	  and	  inactive	  carriers	  [62,	  63].	  Two	  
models	   were	   proposed;	   (i)	   a	   dimer	   with	   the	   translocation	   path	   between	   two	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protomers	   [62],	   consistent	   with	   a	   ping-­‐pong	   mechanism	   [64],	   or	   (ii)	   a	   dimer	  
consisting	  of	  interacting	  protomers	  in	  opposing	  conformations	  [65],	  consistent	  with	  
a	   simultaneous	   mechanism	   [66].	   However,	   these	   models	   were	   no	   longer	   tenable	  
when	  the	  first	  structural	  information	  became	  available.	  
	  
Figure	   3	   Projection	   structure	   of	   the	   yeast	  mitochondrial	   ADP/ATP	   carrier	   Aac3p	   by	  
electron	  crystallography.	  
	  
The	  projection	  structure	  of	  the	  yeast	  ADP/ATP	  carrier	  Aac3p	  in	  complex	  with	  
ATR,	  solved	  by	  electron	  crystallography,	  showed	  that	  the	  protein	   in	  the	  membrane	  
was	   a	   structural	  monomer	  with	   six	   transmembrane	  α-­‐helices	   arranged	  with	   three-­‐
fold	   pseudo-­‐symmetry	   [49]	   (Figure	   3),	   consistent	   with	   the	   three	   homologous	  
sequence	  repeats	  [38]	  (Figure	  2).	  The	  translocation	  path	  for	  adenine	  nucleotides	  was	  
clearly	   through	   the	   centre	   of	   the	   protein.	   These	   features	   were	   at	   odds	   with	   the	  
proposed	   dimer	   models,	   and	   thus	   it	   was	   suggested,	   for	   the	   first	   time,	   that	  
mitochondrial	  ADP/ATP	  carriers	   could	   function	  as	  monomers	   [49].	  There	  were	   two	  
asymmetric	   features	   in	   the	  projection	  map,	  one	  strong	  and	  one	  weak,	  which	  were	  
difficult	  to	  assign	  at	  the	  time	  (Figure	  3).	  Recently,	  the	  structure	  of	  the	  same	  protein	  
in	   complex	   with	   CATR	   was	   solved	   by	   x-­‐ray	   crystallography,	   providing	   an	   atomic	  
model	  for	  the	  interpretation	  of	  the	  projection	  map	  [67].	  The	  strong	  density	  feature	  is	  
likely	   to	   be	   ATR	   and	   the	   weak	   one	   a	   short	   α-­‐helical	   extension	   of	   the	   first	  
transmembrane	  helix	  at	  the	  matrix	  side	  (see	  also	  below)	  (Figure	  3).	  	  
The	  atomic	  structures	  of	  the	  bovine	  AAC1	  first	  [68]	  and	  the	  yeast	  Aac2p	  and	  
Aac3p	   later	   [67]	   confirmed	   a	   monomeric	   structural	   fold.	   Crystallographic	   dimers	  
were	  present	   in	  the	  projection	  map	  of	  yeast	  Aac3p	  [49],	   in	  one	  crystal	   form	  of	  the	  
bovine	  carrier	  [69]	  and	  in	  several	  crystal	  forms	  of	  the	  yeast	  carriers	  [67].	  However,	  in	  
all	   cases	   the	   interaction	   interfaces	   were	   small	   and	   involved	   only	   cardiolipin	  
molecules	  or	  non-­‐conserved	  residues,	  which	  is	  incompatible	  with	  homo-­‐dimerisation	  
[67].	   Other	   analysis	   has	   demonstrated	   that	   the	   yeast	   ADP/ATP	   carriers	   were	  
monomeric	   in	   detergents	   when	   assessed	   by	   size	   exclusion	   chromatography	   [70],	  
analytical	  ultracentrifugation	   [70],	  differential	   tagging	  and	  affinity	  purification	   [71],	  
blue	   native	   electrophoresis	   [72],	   and,	   most	   recently,	   by	   multi-­‐angle	   laser	   light	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scattering	   (Jonathan	  Ruprecht,	   Liz	  Cerson	  and	  Martin	  King,	   unpublished	  data).	   The	  
bovine	  ADP/ATP	  carrier	  was	  also	  shown	  to	  be	  monomeric	  in	  detergent	  by	  analytical	  
ultracentrifugation	  [73].	  When	  the	  yeast	  ADP/ATP	  carrier	  Aac3p	  was	  reconstituted	  in	  
membranes	   at	   lower	   protein/lipid	   ratios	   than	   those	   used	   for	   two-­‐dimensional	  
crystals	   [49],	   only	   small	   crystalline	   patches	   and	   single	   protein	   molecules	   were	  
observed	  by	   atomic	   force	  microscopy	   [74].	   Furthermore,	   transport	   assays	  with	   co-­‐
expressed	  sulfhydryl	  sensitive	  and	  insensitive	  yeast	  ADP/ATP	  carriers	  demonstrated	  
that	  the	  carriers	  function	  as	  monomers	  in	  the	  mitochondrial	  membrane	  [75].	  	  
But	  what	   about	   the	   earlier	   claims	   for	   a	   dimer?	  Determining	   the	   oligomeric	  
conformation	  of	  membrane	  proteins	  is	  technically	  challenging,	  especially	  since	  these	  
proteins	  are	  small,	  hydrophobic	  and	  very	  unstable	  in	  detergent.	  In	  sizing	  techniques,	  
such	   as	   size	   exclusion	   chromatography,	   analytical	   centrifugation,	   and	   blue	   native	  
electrophoresis,	   it	   is	   crucial	   to	   account	   for	   the	   contribution	   of	   the	   lipid/detergent	  
micelle	  to	  the	  total	  mass,	  which	  is	  much	  bigger	  than	  the	  contribution	  of	  the	  carrier	  
protein	  [70,	  76].	  With	  the	  advantage	  of	  hindsight	  all	  of	  the	  inconsistencies	  could	  be	  
explained	   (see	   [77]	   for	   a	   retrospective	   analysis),	   providing	   further	   support	   for	   the	  
monomer	  being	  the	  functional	  unit.	  The	  uncoupling	  protein,	  which	  is	  belongs	  to	  the	  
mitochondrial	   carrier	   family,	   is	   also	   a	   monomer	   [78].	   Recently,	   we	   have	  
characterised	   the	   mitochondrial	   aspartate/glutamate	   carrier,	   another	   family	  
member,	   which	   has	   proved	   to	   be	   a	   structural	   homo-­‐dimer.	   Here,	   dimerisation	   is	  
mediated	   by	   additional	   N-­‐terminal	   domains	   consisting	   of	   EF-­‐hands	   that	   form	   an	  
extensive	   interaction	   interface,	  but	   importantly	   the	  carrier	  domains	   themselves	  do	  
not	  dimerize	  [79].	  Thus	  the	  mitochondrial	  ADP/ATP	  carrier	  functions	  as	  a	  monomer.	  
	  
The	  atomic	  structures	  of	  the	  bovine	  and	  yeast	  ADP/ATP	  carrier	  
The	  first	  atomic	  structure	  to	  be	  determined	  was	  that	  of	  the	  bovine	  ADP/ATP	  carrier	  
AAC1	   in	   complex	  with	  CATR	   [68]	   (Figure	  4A).	  The	   structure	   revealed	   the	   structural	  
fold	  of	  the	  protein	   locked	  in	  the	  cytoplasmic	  conformation	  by	  the	  inhibitor.	  The	  six	  
transmembrane	   α-­‐helices	   are	   highly	   tilted	   and	   form	   an	   α-­‐helical	   barrel	   around	   a	  
water-­‐filled	  cavity.	  Three	  short	  α-­‐helices	  on	  the	  matrix	  side	  of	  the	  carrier	  run	  roughly	  
parallel	   with	   the	   membrane	   plane	   and	   connect	   the	   odd	   and	   even-­‐numbered	   α-­‐
helices	   (Figure	   4A).	   The	   structure	   has	   three-­‐fold	   pseudo-­‐symmetry	   in	   agreement	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with	   the	   three	   sequence	   repeats	   [38]	   and	   the	   projection	   structure	   of	   Aac3p	   [49]	  
(Figure	  4A).	  The	  atomic	  structures	  of	  yeast	  Aac2p	  and	  Aac3p	  have	  a	  very	  similar	  fold	  
(Figure	   4B),	   confirming	   the	   basic	   structure	   consisting	   of	   three	   similar	   domains	  
(primary	  colours	  Figure	  4)	  [67].	  	  
	  
Figure	   4	   Architecture	   of	   the	   bovine	   and	   yeast	   ADP/ATP	   carrier	   by	   x-­‐ray	  
crystallography.	  	  
	  
There	   are	   a	   few	   differences	   between	   the	   yeast	   and	   bovine	   structures.	   First,	   the	  
extreme	  C-­‐terminal	  region	  of	  the	  yeast	  carriers	  folds	  back	  into	  the	  central	  cavity	  as	  a	  
loop,	   which	   is	   absent	   in	   the	   bovine	   carrier	   (Figure	   4B).	   Second,	   the	   yeast	   carriers	  
have	  an	  extra	  helical	  turn	  at	  the	  end	  of	  the	  first	  transmembrane	  helix	  H1,	  which	  is	  a	  
loop	   in	   the	  bovine	  carrier.	  Third,	   the	  N-­‐terminal	   region	  of	   the	   first	   transmembrane	  
helix	  H1	  of	  Aac3p	  extends	   into	   the	   intermembrane	   space	  by	   another	   three	  helical	  
turns	   compared	   to	   the	   bovine	   carrier	   (Figure	   4A	   and	   B).	   In	   contrast,	   Aac2p	   is	  
predicted	   to	   have	   an	   N-­‐terminal	   loop	   region	   of	   22	   amino	   acid	   residues,	   but	   this	  
sequence	  was	  deleted	  in	  the	  construct	  used	  for	  crystallography.	  
	  
Figure	  5	  CATR	  binding	  to	  the	  yeast	  mitochondrial	  ADP/ATP	  carrier	  Aac3p.	  
	  
All	  atomic	  structures	  were	  solved	  in	  complex	  with	  CATR,	  as	  it	  confers	  a	  remarkable	  
increase	   in	   stability	  of	   the	  protein	   [18,	  70]	   (see	  also	  below).	   The	  CATR	  molecule	   is	  
bound	  asymmetrically	  in	  the	  central	  cavity	  [67,	  68].	  In	  the	  yeast	  structures	  CATR	  was	  
modelled	  with	  a	  β-­‐D-­‐glucoside	  ring	  [67]	  (Figure	  5),	  rather	  than	  the	  α-­‐D-­‐glucoside	  in	  
the	   bovine	   structure	   [68,	   69].	   A	   β-­‐D-­‐glucoside	   ring	   is	   consistent	   with	   the	   crystal	  
structure	  of	  ATR	  [80]	  and	  NMR	  studies	  of	  CATR	  and	  ATR	  [81].	  CATR	  differs	  from	  ATR	  
by	  one	  carboxylate	  group	  that	  gives	  extra	  resistance	  to	  unfolding	  of	  yeast	  Aac3p	  by	  
single-­‐molecule	  force	  spectroscopy,	  which	  was	  located	  to	  transmembrane	  H2,	  again	  
consistent	  with	  a	  β-­‐D-­‐glucoside	  ring	  [80,	  81].	  
	  
	  
Figure	  6	  Proline	  and	  serine	  residues	  in	  the	  signature	  motifs	  of	  Aac2p.	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It	  was	  noted	   first	   in	   the	  bovine	   structure	   that	   the	  odd-­‐numbered	  α-­‐helices	  have	  a	  
pronounced	   L-­‐shape	   [68].	   The	   symmetrically	   conserved	   proline	   residues	   of	   the	  
signature	  motif	  PX[DE]XX[RK]	  are	  found	  at	  the	  kink	  in	  these	  helices.	  Similar	  kinks	  are	  
found	  in	  the	  odd-­‐numbered	  α-­‐helices	  of	  the	  yeast	  carriers	  (Figure	  6A),	  even	  though	  
the	   proline	   residue	   in	   transmembrane	  H3	   is	   replaced	   by	   a	   serine	   (Figure	   6B).	   The	  
hydroxyl	  group	  of	   the	  serine	   forms	  an	   interaction	  with	   its	  own	  backbone	  nitrogen,	  
mimicking	  a	  proline	  residue.	  The	  proline	  and	  serine	  residues	  allow	  the	  kink	  to	  occur,	  
because	   the	   hydrogen	   bonding	   arrangement	   of	   the	   helix	   is	   interrupted	   (Figure	   6),	  
but	   the	   kink	   itself	   is	   stabilised	   by	   interactions	  with	   other	   residues	   of	   the	   domain,	  
including	  the	  matrix	  α-­‐helices	  [67].	  	  
	  
Figure	  7	  Cardiolipin	  binding	  site	  of	  the	  yeast	  ADP/ATP	  carrier.	  
	  
Cardiolipin	  binding	  to	  the	  ADP/ATP	  carrier	  
Phosphorous	   NMR	   experiments	   have	   shown	   previously	   that	   cardiolipin	   molecules	  
are	  tightly	  bound	  to	  the	  ADP/ATP	  carrier	  [82].	  Impairment	  of	  cardiolipin	  synthesis	  in	  
yeast	   still	   allows	   growth	   on	   non-­‐fermentable	   carbon	   sources,	   indicating	   that	   the	  
carrier	  is	  still	  functional	  [83],	  but	  in	  man	  it	  leads	  to	  Sengers	  syndrome,	  in	  which	  the	  
carrier	   disappears	   from	   the	   inner	   membrane,	   leading	   to	   a	   severe	   oxidative	  
phosphorylation	   disease	   phenotype	   [84,	   85].	   Three	   tightly	   bound	   cardiolipin	  
molecules	  were	  found	   in	  the	  structure	  of	   the	  bovine	  ADP/ATP	  carrier	   [68,	  69].	  The	  
phosphate	   groups	   were	   hydrogen	   bonded	   to	   the	   N-­‐terminal	   ends	   of	   the	   even-­‐
numbered	   and	   matrix	   α-­‐helices,	   spanning	   the	   inter-­‐domain	   interface.	   The	   yeast	  
structures	   also	   contained	   three	   bound	   cardiolipins	   arranged	   in	   a	   similar	   manner	  
(Figure	  7A)	   [67].	  By	  analysing	  27	  available	  cardiolipin	  binding	  sites	   from	  the	  crystal	  
structures	  we	  made	  several	  observations	  that	  may	  explain	  why	  these	  lipid	  molecules	  
are	  bound	   so	   tightly.	   First,	   preceding	   the	  even-­‐numbered	  and	  matrix	  α-­‐helices	  are	  
the	   conserved	   symmetrical	   sequence	   motifs	   [YWF][RK]G	   and	   [YF]XG,	   respectively.	  
The	   glycine	   residues	   of	   these	   motifs	   are	   in	   the	   loop	   to	   helix	   transition,	   as	   they	  
function	  as	  helix	  breakers.	  As	  a	  consequence,	  the	  amide	  groups	  at	  the	  start	  of	  the	  α-­‐
helices	  do	  not	  have	  hydrogen	  bonding	  partners,	  and	  thus	  the	  phosphate	  groups	  of	  
	   9	  
cardiolipin	   may	   act	   as	   hydrogen	   bond	   acceptors.	   Second,	   the	   bound	   cardiolipin	  
molecules	   are	  most	   likely	   to	   have	   two	   formal	   negative	   charges	   [86],	   because	   the	  
central	   hydroxyl	   group	   does	   not	   form	   a	   hydrogen	   bond	   with	   either	   of	   the	   two	  
phosphate	  moieties	  (Figure	  6B).	  The	  charged	  head	  groups	  of	  cardiolipin	  are	  bound	  in	  
a	   hydrophobic	   environment	   and	   thus	   there	   has	   to	   be	   a	   charge	   compensation	  
mechanism,	   but	   the	   positively	   charged	   residues	   of	   the	   [YWF][RK]G	   motif	   do	   not	  
interact	  directly	  with	  the	  phosphate	  groups	  with	  one	  possible	  exception.	  However,	  
the	  N-­‐terminal	  ends	  of	  the	  even-­‐numbered	  and	  matrix	  α-­‐helices	  will	  have	  a	  positive	  
charge	  from	  the	  helix	  dipole,	  which	  may	  interact	  electrostatically	  with	  the	  negatively	  
charged	  phosphate	  moieties	  of	  cardiolipin.	  Thus	  the	  three	  cardiolipin	  molecules	  are	  
most	   likely	   bound	   by	   several	   hydrogen	   bonds	   and	   by	   electrostatic	   interactions	  
(Figure	  7)	  [67].	  
	  
Figure	  8	  Yeast	  ADP/ATP	  carriers	  in	  the	  membrane	  –	  molecular	  dynamics	  simulations	  
and	  atomic	  force	  microscopy.	  	  	  
	  
The	  position	  of	  the	  ADP/ATP	  carrier	  in	  the	  membrane	  
Several	  molecular	  dynamics	  (MD)	  studies	  have	  been	  done	  with	  the	  bovine	  ADP/ATP	  
carrier	   [87-­‐89]	   and	   the	   yeast	   ADP/ATP	   carrier	   Aac2p	   (Antoniya	   Aleksandrova,	  
unpublished	   data),	   which	   have	   shown	   a	   consistent	   pose	   in	   the	   membrane.	   The	  
cytoplasmic	   side	  of	   the	   carrier	   is	   virtually	   flush	  with	   the	   surface	  of	   the	  membrane	  
(Figure	   8),	   showing	   only	   the	   central	   cavity	   as	   a	   hole	   (Figure	   8A).	   The	   matrix	   side	  
protrudes	  from	  the	  membrane	  by	  7-­‐10	  Å	  and	  thus	  the	  matrix	  side	  can	  be	  seen	  on	  the	  
surface	   (Figure	   8B).	   These	   observations	   agree	   well	   with	   high-­‐resolution	   AFM	  
topographs	   of	   the	   two-­‐dimensional	   crystals,	   similar	   to	   those	   shown	   in	   Figure	   2	  
(Figure	   8).	   The	   crystals	   consist	   of	   rows	   of	   Aac3p	   crystallographic	   dimers	   with	  
alternating	  orientations	  as	  can	  be	  clearly	  seen	  in	  the	  AFM	  topograph	  [74]	  (Figure	  8C).	  
The	  measured	  difference	  in	  height	  between	  the	  differently	  oriented	  rows	  of	  Aac3p	  is	  
~7	  Å,	  which	  agrees	  well	  with	  the	  available	  atomic	  structures	  [67,	  68].	  	  
	  
Identification	  of	  the	  substrate	  binding	  site	  of	  the	  ADP/ATP	  carrier	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The	  ADP/ATP	  carrier	  has	  a	  very	  strict	  substrate	  specificity,	  as	  was	  noted	  first	  for	  the	  
bovine	  ADP/ATP	  carrier	  [6].	  Recently,	  the	  substrate	  specificity	  of	  the	  human	  carrier	  
was	  determined	   [89].	   Remarkably,	   only	  ADP	   and	  ATP	   and	   their	   deoxy	   variants	   are	  
transported.	   Thus	   the	   commonly	   used	   names	   adenine	   nucleotide	   translocase	   or	  
translocator	  would	  appear	  to	  be	  misnomers,	  as	  neither	  AMP	  nor	  any	  other	  adenine	  
nucleotides	  are	  transported.	  
	  
Figure	  9	  Different	  approaches	  used	  for	  identification	  of	  the	  substrate	  binding	  site.	  	  
	  
Three	   independent	   approaches	   have	   been	   applied	   to	   locate	   the	   substrate	  
binding	  site.	  The	  first	  approach	  used	  comparative	  structural	  models	  combined	  with	  
chemical	   and	  distance	   constraints	   to	   identify	   conserved	   sites	   that	  were	   capable	  of	  
discriminating	   between	   different	   amino	   and	   keto	   acid	   substrates	   of	  mitochondrial	  
carriers	  [90,	  91].	  It	  was	  anticipated	  that	  the	  models	  may	  not	  be	  correct,	  and	  thus	  the	  
distance	   restraints	  were	  applied	   loosely.	  These	   searches	   located	  a	  unique	  site	   that	  
could	  explain	  the	  specificity	  of	  known	  transporters.	  The	  main	  contact	  points	  involved	  
in	  substrate	  binding	  were	  located	  on	  the	  even-­‐numbered	  α-­‐helices.	  Inspection	  of	  the	  
same	   site	   in	   the	   ADP/ATP	   carrier	   showed	   that	   it	   was	   also	   able	   to	   bind	   adenine	  
nucleotides.	  On	  this	  basis	   it	  was	  proposed	  that	  the	  substrate	  binding	  site	  of	  bovine	  
AAC1	  consisted	  of	  G182,	  I183	  and	  Y186	  for	  binding	  of	  the	  adenine	  moiety	  and	  R79,	  
K22	  and	  R279	  for	  binding	  of	  the	  phosphate	  groups	  [90,	  91]	  (Figure	  9A).	  
The	  second	  approach	  exploited	  the	  principle	  that	  mitochondrial	  carriers	  have	  
a	  high	  degree	  of	  three-­‐fold	  symmetry	  [38],	  whereas	  the	  transported	  substrates	  are	  
asymmetric	   in	   structure	   and	   chemistry	   [92].	   Therefore,	   the	   carriers	   must	   have	  
evolved	   asymmetric	   substrate	   binding	   sites	   as	   adaptations	   to	   the	   asymmetric	  
substrates.	  Based	  on	  sequence	   information	  only,	  a	  score	  was	  devised	  to	  assess	  the	  
degree	  of	  symmetry	  and	  conservation	  of	  all	  residues	   in	  mitochondrial	  carriers	  [92].	  
For	  all	   known	  subfamilies	  of	  mitochondrial	   carriers	  conserved	  asymmetric	   residues	  
were	   found	   to	   cluster	   consistently	   at	   a	   site	   that	   overlapped	   with	   the	   substrate	  
binding	  site	  mentioned	  above	  [90,	  91].	  Importantly,	  no	  other	  clusters	  of	  asymmetric	  
residues	  were	  found	  on	  the	  water-­‐accessible	  surfaces	  of	  the	  carriers,	  indicating	  that	  
mitochondrial	  carriers	  have	  a	  single	  substrate	  binding	  site.	  For	  the	  ADP/ATP	  carrier	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the	  cluster	  of	  asymmetric	  residues	  was	  more	  extensive,	  but	  involved	  the	  asymmetric	  
residues	  G182,	  Y186,	  S227	  and	  K22	  and	  the	  symmetric	  residues	  R79	  and	  R279,	  which	  
potentially	   allow	   coupling	   to	   a	   symmetric	   transport	   mechanism	   (Figure	   9B).	   In	  
addition,	  there	  are	  asymmetric	  polar	  residues	  on	  the	  cytoplasmic	  side	  (K91	  and	  N87)	  
and	  matrix	  side	  (R235	  and	  T138)	  (see	  below).	  
The	  third	  approach	  used	  molecular	  dynamics	  simulations	  to	  identify	  residues	  
of	  the	  bovine	  mitochondrial	  ADP/ATP	  carrier	  that	  are	  involved	  in	  the	  trajectory	  and	  
binding	  of	  ADP	  in	  the	  cavity	  [87,	  89,	  93].	  Although	  ADP	  binds	   in	  many	  places	  along	  
the	  trajectory,	  two	  consensus	  sites	  emerged	  from	  these	  three	  studies.	  The	  first	  site	  
involves	   the	   aforementioned	   residues,	   but	   the	   β-­‐phosphate	   binds	   to	   R235	   (Figure	  
9C).	  The	  second	  involves	  residues	  R79,	  R279	  and	  R235	  for	  binding	  of	  the	  phosphate	  
moieties,	  and	  K22,	  S21	  and	  A284	  for	  binding	  of	  the	  adenine	  moiety	  (Figure	  9D).	  	  
A	  consensus	  for	  the	  central	  substrate	  binding	  site	  emerges	  from	  comparison	  
of	   the	   three	   approaches,	   which	   is	   shown	   in	   the	   yeast	   Aac2p	   with	   a	   modelled	  
substrate	   (Figure	   10).	   The	   adenine	   moiety	   has	   an	   aromatic	   stacking	   arrangement	  
with	  Y203,	  hydrophobic	  interactions	  with	  G199	  and	  I200,	  and	  a	  hydrogen	  bond	  with	  
S245	  (Y186,	  G182,	  I183,	  and	  S227	  in	  bovine	  AAC1,	  respectively).	  The	  hydroxyl	  group	  
of	  the	  Y203	  might	  form	  a	  hydrogen	  bond	  with	  the	  hydroxyl	  group	  of	  the	  ribose.	  As	  
depicted,	   the	   phosphate	   groups	   of	   ATP	   are	   bound	   to	   K38,	   R96,	   and	   R294,	   which	  
leaves	  one	  net	  negative	  charge.	  If	  ADP	  is	  bound	  to	  the	  same	  site	  in	  a	  similar	  way,	  the	  
substrate	  would	  be	  neutralised.	  This	  notion	  is	  consistent	  with	  an	  electrophoretic	  or	  
electrogenic	  exchange	  [21,	  22],	  as	  there	  would	  be	  a	  net	  negative	  charge	  difference.	  	  	  
	  
Figure	  10	  Proposed	  substrate	  binding	  site	  of	  the	  mitochondrial	  ADP/ATP	  carrier.	  	  
	  
What	  about	   the	  other	  charged	  asymmetric	   residues	   in	   the	  cavity,	  K91	  and	  R235	   in	  
AAC1	   (Figure	   9B)?	   The	   molecular	   dynamics	   studies	   have	   shown	   that	   in	   the	  
cytoplasmic	  conformation	  R235	  is	  involved	  in	  binding	  of	  β-­‐phosphate	  [87,	  89,	  93].	  In	  
this	   way	   binding	   of	   the	   terminal	   phosphate	   might	   hold	   the	   highly	   flexible	   ADP	  
molecule	  in	  a	  pose	  that	  would	  lead	  to	  the	  disruption	  of	  the	  matrix	  network.	  Residue	  
K91	  may	  fulfil	  a	  similar	  role	  for	  the	  binding	  of	  ATP	  when	  the	  carrier	  is	  in	  the	  matrix	  
conformation.	   These	   additional	   intermittent	   interactions	   could	   explain	   the	   charges	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of	  −0.7	  and	  +0.3	  upon	  binding	  of	  ATP	  and	  ADP,	  respectively,	  in	  direct	  measurement	  
of	   electrical	   currents	   of	   ADP/ATP	   transport	   [64].	   The	   location	   of	   the	   substrate	  
binding	   site	   is	   supported	   also	   by	   the	   observation	   that	   the	   photo-­‐activated	   ADP	  
analogue	  2-­‐	   azido[α-­‐32P]adenosine	  diphosphate	   reacts	  with	   I183	   in	  AAC1	   [94].	   The	  
tyrosine	  residue	  (Y186	  in	  AAC1),	  involved	  in	  an	  aromatic	  stacking	  arrangement	  with	  
the	  adenine	  ring,	  is	  also	  critical	  for	  the	  function	  of	  the	  carrier	  [95].	  	  
The	   proposed	   substrate	   binding	   site	   has	   several	   interesting	   properties.	   The	  
location	  corresponds	  approximately	  to	  the	  middle	  of	  the	  membrane,	  as	  observed	  for	  
other	   transporters.	   The	   water-­‐filled	   cavity	   allows	   the	   substrate	   to	   move	   to	   the	  
middle	  of	  the	  membrane,	  which	  is	  energetically	  the	  most	  unfavourable	  position	  for	  a	  
charged	   and	   polar	   substrate.	   The	   site	   could	   function	   as	   a	   pivot	   point	   for	  
conformational	  changes,	  allowing	  the	  alternating	  access	  of	  the	  site	  to	  either	  side	  of	  
the	  membrane.	  The	  main	  contact	  points	  I,	  II	  and	  III	  of	  the	  common	  substrate	  binding	  
site	  are	  located	  on	  the	  even	  numbered	  α-­‐helices	  H2,	  H4	  and	  H6,	  respectively,	  which	  
are	  related	  by	  three-­‐fold	  pseudo-­‐symmetry	  allowing	  the	  binding	  of	  the	  substrate	  to	  
be	  coupled	  to	  a	  common	  structural	  mechanism	  of	  transport	  (Figure	  	  10).	  	  
	  
Figure	  11	  Main	  functional	  elements	  of	  the	  mitochondrial	  ADP/ATP	  carrier.	  	  
	  
Salt	  bridge	  networks	  of	  the	  mitochondrial	  ADP/ATP	  carrier	  
The	  structure	  of	  the	  bovine	  AAC1	  showed	  that	  the	  charged	  residues	  of	  the	  signature	  
motif	  PX[DE]XX[RK]	  form	  a	  salt	  bridge	  network	  on	  the	  matrix	  side	  when	  the	  carrier	  is	  
in	   the	   cytoplasmic	   conformation	   [68].	   Formation	   and	   disruption	   of	   this	   salt	   bridge	  
network	  had	  previously	  been	  proposed	  on	  the	  basis	  of	  second-­‐site	  revertants	  [43].	  A	  
similar	  arrangement	  can	  be	  observed	  in	  the	  structures	  of	  the	  yeast	  Aac2p	  and	  Aac3p	  
(Figure	  10),	  but	  we	  noticed	  that	  in	  one	  domain	  a	  glutamine	  residue	  forms	  hydrogen	  
bonds	  with	   both	   residues	   of	   the	   salt	   bridge	   [67].	   Equivalently	   arranged	   glutamine	  
residues	   could	   be	   present	   in	   other	   mitochondrial	   carriers,	   as	   they	   are	   highly	  
conserved,	  but	   their	  number	  per	  protein	  varies,	   indicating	  different	  adaptations	   to	  
function.	   We	   have	   called	   this	   interaction	   the	   glutamine	   brace,	   which	   serves	   to	  
increase	  the	  overall	  interaction	  energy	  of	  the	  matrix	  network.	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Our	   analysis	   of	   the	   carrier	   symmetry	   revealed	   a	   highly	   conserved	   and	  
symmetrical	  [FY][DE]XX[RK]	  motif	  on	  the	  cytoplasmic	  side	  of	  the	  carrier	  (Figure	  11),	  
which	  also	  has	  the	  propensity	  to	  form	  a	  salt	  bridge	  network	  [92].	  These	  residues	  are	  
located	   on	   the	   even-­‐numbered	   α-­‐helices,	   whereas	   the	   residues	   of	   the	   matrix	  
network	  are	  on	  the	  odd-­‐numbered	  α-­‐helices.	  In	  the	  cytoplasmic	  state	  these	  residues	  
are	  not	  engaged	   in	   interactions	  [67],	  so	   it	  was	  proposed	  that	  the	  network	  forms	   in	  
the	  matrix	  conformation.	  Both	  networks	  align	  with	  the	  water-­‐membrane	  interface	  at	  
either	   side	  of	   the	  carrier,	  where	  solute	  access	   to	   the	  central	   substrate	  binding	  site	  
may	   be	   controlled	   by	   closing	   and	   opening	   of	   the	   carrier	   to	   either	   side	   of	   the	  
membrane.	  Based	  on	  these	   functional	   features,	  we	  proposed	  an	  alternating	  access	  
mechanism	  of	  substrate	  exchange	  by	  the	  carriers	  (Figure	  12)	  [92].	  In	  the	  mechanism,	  
substrate	   binding	   in	   one	   conformation	   allows	   the	   conversion	   to	   the	   other	  
conformation	   by	   the	   disruption	   and	   formation	   of	   these	   networks,	   causing	   the	  
alternating	  opening	  and	  closing	  of	   the	  carrier	   to	  either	  side	  of	   the	  membrane.	  The	  
high	   interaction	   energies	   of	   the	   two	   networks	   will	   prevent	   the	   interconversions	  
between	  conformations	   in	   the	  absence	  of	   substrate,	  which	  would	  account	  well	   for	  
the	   observed	   equimolar	   exchange	   of	   ADP	   and	   ATP.	   Semi-­‐quantitatively,	   the	  
interaction	  energies	   involved	   in	   substrate	  binding	  and	   formation	  of	   the	   salt	  bridge	  
networks	  are	  balanced,	  which	  allow	  the	  interconversions	  of	  states	  to	  occur	  [96].	  	  
	  
Figure	  12	  Proposed	  transport	  mechanism	  of	  the	  mitochondrial	  ADP/ATP	  carrier.	  	  
	  
Only	  recently	  have	  we	  been	  able	  to	  provide	  experimental	  support	  for	  the	  formation	  
of	  the	  cytoplasmic	  network.	  First	   it	  was	  shown	  that	  the	  charges	  of	  the	  cytoplasmic	  
salt	  bridge	  network	  are	  crucial	  for	  the	  transport	  cycle	  [67].	  Residues	  of	  the	  proposed	  
cytoplasmic	   network	   were	   mutated	   to	   engineer	   networks	   with	   only	   positively	  
charged	   residues,	   only	   negatively	   charged	   residues,	   or	   with	   residues	   that	   had	   the	  
opposite	  charge	  of	  those	  of	  the	  wild-­‐type	  carrier.	  Mutant	  carriers	  with	  all	  positively	  
or	   all	   negatively	   charged	   residues	   (three	  mutations	   each)	   were	   not	   active,	   as	   the	  
same	   charge	   opposed	   their	   interactions.	   However,	   the	   mutant	   with	   the	   charged	  
residues	  of	  the	  cytoplasmic	  network	  interchanged	  (six	  mutations	  in	  total)	  was	  active,	  
albeit	   to	  only	  14%	  of	   the	  wild-­‐type	   rate.	   This	   result	   indicated	   that	   the	   cytoplasmic	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network	  must	   form	  as	  part	  of	   the	   transport	  cycle,	   though	   it	  does	  not	  prove	  that	   it	  
forms	  in	  the	  matrix	  state.	  To	  demonstrate	  this,	  we	  have	  developed	  a	  new	  approach	  
that	   combines	   mutagenesis	   with	   protein	   thermostability	   measurements	   based	   on	  
the	   thiol-­‐reactive	   CPM	  probe.	   CPM	   forms	   a	   blue	   fluorescent	   adduct	   after	   reaction	  
with	  an	  exposed	  protein	   thiol	   (Figure	  13A).	  The	  probe	  was	  used	   in	  an	  assay	   in	   the	  
Stevens	   lab	  to	  test	  the	  relative	  stability	  of	  membrane	  proteins	  to	  aid	  crystallisation	  
trials	   [97],	   but	  we	  have	   adapted	   the	   assay	   and	  developed	   it	   as	   a	   powerful	   tool	   to	  
obtain	   key	   biological	   information.	   In	   the	   procedure,	   the	   temperature	   of	   purified	  
protein	   samples	   is	   increased	   from	   25	   to	   90	   °C,	   buried	   cysteine	   residues	   become	  
solvent	  exposed	  due	  to	  thermal	  denaturation	  of	  the	  protein	  and	  an	  unfolding	  curve	  
is	  obtained	  through	  fluorescence	  measurements	  [98].	  The	  peak	   in	  the	  derivative	  of	  
the	   unfolding	   curve,	   the	   “melting	   temperature”,	   provides	   a	   relative	   measure	   of	  
protein	  stability.	  We	  have	  used	  the	  assay	  to	  provide	  information	  on	  detergent,	  lipid,	  
substrate	   and	   inhibitor	   interactions	   with	   various	   mitochondrial	   carriers	   and	  
uncoupling	  proteins	  [78,	  96,	  98].	  	  
	  
Figure	  13	  Thermostability	  of	   purified	  wild-­‐type	  ADP/ATP	   carrier	   in	  detergent	   in	   the	  
presence	  of	  inhibitors	  and	  ADP.	  	  
	  
The	  assay	  has	  also	  been	  used	  to	  study	  the	  conformations	  of	  the	  ADP/ATP	  carrier	  of	  
the	   thermophilic	   fungus	   Myceliophthora	   thermophile,	   which	   is	   more	   stable	   in	  
detergent	  in	  the	  unliganded	  form	  [96].	  The	  unfolding	  profiles	  of	  the	  wild-­‐type	  carrier	  
were	  determined	  in	  the	  absence	  or	  presence	  of	  CATR	  or	  BKA	  (Figure	  13B	  and	  C).	  As	  
the	  binding	  of	  these	  inhibitors	   is	  state-­‐dependent,	   it	  was	  necessary	  to	  also	  add	  the	  
substrate	   ADP	   in	   small	   amounts	   to	   allow	   cycling	   between	   states	   to	   obtain	   one	  
inhibited	   population	   [15,	   16,	   96].	   In	   the	   absence	   of	   inhibitor,	   the	   carrier	   had	   a	  
relatively	  low	  apparent	  melting	  temperature	  of	  ~50	  °C.	  Addition	  of	  CATR	  resulted	  in	  
a	   33	   °C	   increase	   in	   the	   apparent	   melting	   temperature	   of	   the	   carrier,	   whereas	  
addition	   of	   BKA	   only	   led	   to	   an	   11	   °C	   increase	   (Figure	   13A	   and	   B).	   Remarkably,	   a	  
raised	   baseline	   was	   observed	   in	   the	   presence	   of	   BKA,	   indicating	   that	   one	   of	   two	  
cysteine	   residues	   in	   the	   protein	   had	   become	   exposed	   (Figure	   13A).	   Mutagenesis	  
demonstrated	  that	  this	  cysteine	  residue	  belongs	  to	  a	  highly	  conserved	  [DE]C	  motif	  in	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the	  matrix	   α-­‐helices	   [96],	   which	   is	   also	   the	   target	   of	   sulfhydryl	   reagents	   [75]	   and	  
cross-­‐linking	  under	  oxidising	  conditions	   [59-­‐61],	  but	  only	  when	  the	  carrier	   is	   in	   the	  
BKA-­‐inhibited	   conformation.	   Thus	   the	   CPM	   assay	   can	   be	   used	   to	   distinguish	   the	  
conformations	   of	   the	   ADP/ATP	   carrier.	   CATR	   is	   bound	   to	   the	   central	   cavity	   by	   an	  
extensive	  network	  of	  salt	  bridges,	  hydrogen	  bonds	  and	  hydrophobic	  contacts,	  cross-­‐
linking	   most	   of	   the	   transmembrane	   α-­‐helices,	   which	   could	   easily	   account	   for	   the	  
large	  increase	  in	  stability	  (Figure	  5).	  Although	  it	  is	  not	  known	  how	  BKA	  binds,	  it	  is	  a	  
relatively	   long	   and	   flexible	   molecule	   with	   only	   three	   carboxylic	   groups,	   providing	  
fewer	  and	  weaker	  binding	  opportunities	  than	  CATR,	  consistent	  with	  these	  results.	  
	  
Figure	  14	  Cytoplasmic	  salt	  bridge	  network	  of	  the	  mitochondrial	  ADP/ATP	  carrier	  
	  
The	  cytoplasmic	  salt	  bridge	  network	  forms	  in	  the	  matrix	  state	  
Since	  the	  conformation	  of	  the	  carrier	  can	  be	  defined	  by	  the	  CPM	  assay,	  we	  used	  it	  to	  
study	   the	   effect	   of	   mutations	   of	   the	   cytoplasmic	   network	   on	   the	   matrix	   and	  
cytoplasmic	  conformation	  [96].	  A	  series	  of	  mutations	  were	  introduced	  with	  the	  aim	  
to	  increase	  or	  decrease	  the	  overall	  interaction	  energy	  of	  the	  cytoplasmic	  network	  of	  
the	   ADP/ATP	   carrier.	   Previously,	   we	   have	   introduced	   a	   semi-­‐quantitative	  measure	  
for	   the	   interaction	   energy	   of	   these	   networks	   by	   counting	   the	   number	   of	   potential	  
salt	   bridge	   and	   hydrogen	   bond	   interactions,	   assuming	   that	   hydrogen	   bonds	   have	  
about	  half	  the	  interaction	  energy	  of	  a	  salt	  bridge	  [92].	  On	  this	  basis	  the	  cytoplasmic	  
network	  of	  the	  wildtype	  has	  a	  putative	  interaction	  energy	  of	  2.5,	  based	  on	  two	  salt	  
bridges	   and	   one	   hydrogen	   bond	   (Figure	   14).	   By	   introducing	   mutations,	   the	  
interaction	  energy	  of	  the	  cytoplasmic	  network	  was	  varied	  from	  3.0	  to	  0.5	  (Figure	  14).	  
Next	   the	   mutant	   and	   wild-­‐type	   carriers	   were	   purified,	   and	   the	   effect	   of	   the	  
mutations	  on	  the	  thermostability	  was	  determined	  when	  the	  carriers	  were	  locked	  in	  
either	   the	   cytoplasmic	   or	   the	   matrix	   state	   with	   CATR	   plus	   ADP	   or	   BKA	   plus	   ADP,	  
respectively.	   The	   thermostability	   of	   the	   unliganded	   or	   CATR-­‐inhibited	   carrier	   was	  
unaffected	   by	   the	  mutations,	  whereas	   the	   thermostability	   of	   BKA-­‐inhibited	   carrier	  
correlated	   with	   the	   interaction	   energy	   of	   the	   cytoplasmic	   salt	   bridge	   network,	  
demonstrating	   the	   formation	  of	   the	   cytoplasmic	  network	   in	   that	   state	   (Figure	   15).	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The	  data	  also	  support	  the	  notion	  that	  the	  salt	  bridge	  interactions	  of	  the	  cytoplasmic	  
network	  form	  simultaneously	  [96].	  	  
	  
Figure	   15	   Thermostability	   of	   the	   BKA-­‐inhibited	   conformation	   is	   dependent	   on	   the	  
interaction	  energy	  of	  the	  cytoplasmic	  network.	  	  
	  
Towards	  a	  structural	  model	  of	  the	  alternating	  access	  mechanism	  
Currently	   there	   is	  no	   structural	  model	  of	   the	  matrix	   conformation,	  which	  hampers	  
our	   ability	   to	   understand	   the	   transport	   mechanism.	   Careful	   analysis	   of	   the	   polar	  
interactions	   in	   the	   bovine	   and	   yeast	   structures	   has	   shown	   that	   there	   are	   more	  
interactions	   within	   the	   domains	   than	   between	   the	   domains	   [67].	   The	   most	  
significant	   and	   conserved	   inter-­‐domain	   interactions	   are	   the	   salt	   bridge	   networks,	  
which	  clearly	  have	  a	  defined	  functional	   role.	  Most	  of	   the	   intra-­‐domain	   interactions	  
are	  on	  the	  matrix	  side	  of	  the	  carrier,	  cross-­‐linking	  the	  matrix	  and	  transmembrane	  α-­‐
helices	   together.	   On	   the	   cytoplasmic	   side	   are	   many	   aromatic	   residues	   that	   may	  
stabilise	  the	  domain	  structure	  through	  aromatic	  interactions	  and	  there	  are	  very	  few	  
polar	   interactions	   between	   the	  α-­‐helices.	   Thus,	   it	   is	   likely	   that	   the	   conformational	  
changes	  involve	  domain	  movements	  as	  rigid	  bodies.	  
	  
Figure	   16	   Conserved	   properties	   of	   the	   inter-­‐domain	   interfaces	   suggest	   a	   domain-­‐
based	  mechanism	  of	  transport.	  	  
	  
The	  movements	  of	  the	  domains	  as	  part	  of	  the	  transport	  cycle	  are	  not	  known,	  
but	  inspection	  of	  the	  inter-­‐domain	  surfaces	  provided	  some	  clues	  [67].	  Normally,	  the	  
side	   chains	   of	   the	   inter-­‐helical	   interfaces	   interact	   in	   a	   “lock	   and	   key”	  manner,	   but	  
that	   is	   not	   the	   case	   for	   the	   inter-­‐domain	   interfaces	   of	   the	   ADP/ATP	   carrier.	   The	  
surface	   of	   the	   inter-­‐domain	   interfaces	   on	   the	   odd-­‐numbered	   α-­‐helices	   consists	  
almost	  entirely	  of	  residues	  with	  no	  or	  small	  side	  chains,	  except	  for	  the	  cytoplasmic	  
ends	   (Figure	   16A).	   Among	   them	   are	   glycine	   residues	   of	   the	   well-­‐conserved	  
symmetrical	  sequence	  motif	  GXXXG,	  which	  are	  on	  the	  same	  face	  of	  the	  helix	  and	  are	  
important	   for	   function	   [99].	   These	   motifs	   are	   commonly	   found	   in	   membrane	  
proteins	   in	   regions	   of	   close	   inter-­‐helical	   contact	   [100].	   On	   the	   even-­‐numbered	   α-­‐
	   17	  
helices,	  hydrophobic	  residues	  face	  the	  membrane	  whereas	  hydrophilic	  residues	  face	  
the	   cavity,	   neither	   pointing	   towards	   the	   interface	   except	   for	   a	   few	   small	   residues	  
(Figure	   16B.	   This	   analysis	   indicated	   that	   the	   inter-­‐domain	   interfaces	   are	   relatively	  
smooth,	  suggesting	  that	  the	  even-­‐numbered	  α-­‐helices	  may	  move	  across	  the	  surface	  
of	  the	  odd-­‐numbered	  α-­‐helices,	  during	  the	  domain	  motions	  (Figure	  16C).	  There	  are	  
many	  possibilities	  for	  the	  motions	  of	  the	  domains,	  but	   in	  the	  cytoplasmic	  to	  matrix	  
transition	  the	  cytoplasmic	  salt	  bridge	  network	  must	  form	  in	  the	  matrix	  state,	  which	  
indicates	  rotation	  of	  the	  domains	  into	  the	  centre	  (Figure	  16C).	  
	  
Conclusions	  
In	  this	  review	  we	  have	  described	  recent	  progress	  towards	  a	  transport	  mechanism	  for	  
the	   mitochondrial	   ADP/ATP	   carrier.	   The	   mechanism	   is	   based	   on	   a	   monomeric	  
protein,	  which	  has	   all	   of	   the	   functional	   elements	   of	   a	   transporter;	   a	   single	   central	  
substrate	   binding	   site	   and	   two	   networks	   on	   either	   side	   of	   the	   membrane	   that	  
provide	  alternating	  access	  to	  the	  binding	  site.	  These	  features	  are	  consistent	  with	  the	  
“single	   binding	   centre	   gated	   pore	  mechanism”	   originally	   proposed	   by	   Klingenberg	  
[15,	   16],	   but	   only	   if	   the	   carriers	   function	   as	   monomers	   [77].	   It	   is	   likely	   that	   the	  
alternating	  opening	  and	  closing	  of	  the	  carrier	  requires	  the	  simultaneous	  rotation	  of	  
the	  three	  domains,	  which	  is	  a	  unique	  mechanism	  for	  transport	  proteins.	  Proof	  of	  this	  
concept	   will	   required	   the	   structure	   of	   the	   matrix	   conformation	   and	   the	  
conformational	  changes	  to	  be	  determined.	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Legends	  to	  the	  figures	  
	  
	  
Figure	   1.	  Mitochondrial	   ADP/ATP	   and	   phosphate	   carriers	   and	   ATP	   synthase.	   The	  
mitochondrial	   ADP/ATP	   carrier	   and	   phosphate	   carrier	   are	   shown	   in	   orange	   and	  
brown,	  respectively.	  ATP	  synthase	  is	  shown	  as	  a	  poly-­‐alanine	  model	  based	  on	  single	  
particle	   analysis	   [101].	   The	   complex	   consists	   of	   catalytic	   subunits	   α	   (red)	   and	   β	  
(yellow);	   central	   stalk	   subunits	   c	   (magenta),	   d	   (purple),	   e	   (light	   blue),	   and	   g	   (dark	  
blue);	  peripheral	  stalk	  subunits	  OSCP	  (blue),	  F6	  (violet),	  b	  (dark	  red)	  and	  d	  (orange);	  
proton-­‐translocating	   subunit	   a	   (green);	   subunit	   A6L	   (marine).	   Eight	   proton	  
translocation	   steps	   are	   required	   to	  make	   three	   ATP	  molecules,	   or	   2.7	   H+	   per	   ATP	  
[102].	  Key	  transport	  steps	  are	  indicated	  by	  arrows.	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Figure	   2	   Topology	   model	   of	   the	   yeast	   ADP/ATP	   carrier	   Aac3p.	   Red	   dotted	   lines	  
indicate	   the	  borders	  of	   the	   three	   sequence	   repeats	  of	   the	   tripartite	   structure.	   The	  
red	   residues	   are	   conserved	   in	   all	   three	   repeats,	   whereas	   the	   orange	   residues	   are	  
conserved	   in	   two	   out	   of	   three	   repeats.	   The	   loops	   in	   the	  mitochondrial	  matrix	   are	  
named	  M1,	  M2	  and	  M3,	  whereas	  the	  termini	  and	  cytoplasmic	  loops	  are	  named	  C1,	  
C2,	  C3	  and	  C4.	  The	  helices	  are	  indicated	  with	  Roman	  numerals	  on	  the	  left	  hand	  side	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Figure	  3	  Projection	  structure	  of	  the	  yeast	  mitochondrial	  ADP/ATP	  carrier	  Aac3p	  by	  
electron	  crystallography.	  Projection	  electron	  density	  map	  of	  Aac3p	  at	  5-­‐Å	  resolution	  
calculated	   from	   merged	   amplitudes	   and	   phases	   from	   two	   independent	   crystal	  
lattices	  with	  p22121	  symmetry	   imposed	  [49].	  A	  unit	  cell	   is	  displayed	  with	  the	  a-­‐axis	  
(42.5	  Å)	  vertical	  and	  the	  b-­‐axis	  (172.1	  Å)	  horizontal.	  Also	  shown	  are	  the	  2-­‐fold	  axes	  
perpendicular	  to	  the	  membrane	  and	  the	  screw	  axes	  in	  the	  plane	  of	  the	  membrane.	  
Solid	   lines	   indicate	  density	  above	   the	  mean,	  while	  negative	  contours	  are	  shown	  as	  
dotted	  lines.	  The	  rounded	  triangles	  (shown	  in	  red)	  emphasise	  the	  three-­‐fold	  pseudo-­‐
symmetry	   of	   Aac3p.	   The	   strong	   and	  weak	   asymmetrical	   densities	   are	   indicated	   by	  
bold	  and	  light	  black	  circles,	  respectively.	  Because	  of	  the	  crystal	  symmetry	  there	  are	  
rows	   of	   crystallographic	   dimers	   of	   yeast	   Aac3p	   [67],	   oriented	   up	   and	   down	  
alternatingly.	  The	  Aac3p	  structural	  models	  are	  shown	  in	  cartoon	  representation	  and	  
rainbow	  colour	  scheme	  from	  the	  N-­‐terminus	  in	  blue	  to	  the	  C-­‐terminus	  in	  red.	  CATR	  is	  
shown	  in	  a	  ball	  and	  stick	  presentation.	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Figure	   4	   Architecture	   of	   the	   bovine	   and	   yeast	   ADP/ATP	   carrier	   by	   x-­‐ray	  
crystallography.	   Structures	   of	   the	   bovine	   ADP/ATP	   carrier	   AAC1	   (1OKC)	   [68]	   (left)	  
and	   the	   yeast	   ADP/ATP	   carrier	   Aac3p	   (4C9Q)	   [67]	   (right).	   Repeats	   1,	   2	   and	   3	   are	  
shown	  in	  blue,	  yellow	  and	  red	  cartoon	  representation,	  respectively.	  Residues	  1	  and	  
294-­‐297	  are	  missing	   in	   the	   structure	  of	  AAC1,	  whereas	   residues	  1-­‐2,	   149-­‐155,	   and	  
208-­‐214	   are	  missing	   in	   the	   structure	  of	  Aac3p,	   as	   these	  protein	   regions	   are	  highly	  
mobile.	  Also	  shown	  is	  CATR	  in	  cyan	  ball	  and	  stick	  representation.	  	  
	  
	  






Figure	  5	  Carboxyatractyloside	  binding	  to	  the	  yeast	  mitochondrial	  ADP/ATP	  carrier	  
Aac3p.	   CATR	   is	   shown	   in	   stick	   and	   sphere	   representation	   bound	   to	   Aac3p	   (4C9Q)	  
[67]	  and	  is	  modelled	  with	  a	  β-­‐D-­‐glucoside	  ring	  [80].	  The	  functional	  moieties	  of	  CATR	  
are	   also	   indicated.	   Residues	   interacting	  with	   the	   inhibitor	   are	   shown	   in	   blue	   stick	  
representations	  and	  are	   labelled	  accordingly.	  Polar	   interactions	  between	  CATR	  and	  
residues	  are	  shown	  as	  black	  dashed	  lines.	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Figure	   6	   Proline	   and	   serine	   residues	   in	   the	   signature	   motifs	   of	   Aac2p.	   (A)	   The	  
signature	  motif	   of	   H1	   and	   (B)	   of	  H3.	   Residues	   interacting	  with	   the	   side-­‐chains	   are	  
shown	   in	   line	   representation.	   The	   positively	   charged,	   negative	   charged,	   polar	   and	  
proline	   residues	   of	   the	   signature	  motif	   (sequence	   shown	   below)	   are	   in	   blue,	   red,	  
green	   and	   purple,	   respectively.	   Hydrogen	   bonds	   involving	   backbone	   atoms	   are	  
shown	  as	  thick	  black	  dotted	  lines,	  hydrogen	  bonds	  not	  involving	  backbone	  atoms	  are	  
shown	  as	  thin	  black	  dotted	  lines.	  The	  density,	  shown	  as	  a	  blue	  mesh,	  is	  a	  2mFo-­‐DFc	  
map,	   contoured	  at	  1	  σ,	   and	  displayed	  within	  2	  Å	  of	   the	  atoms.	   In	   (B),	   the	  unusual	  
hydrogen	   bond	   from	   the	   side-­‐chain	   of	   Ser147	   to	   its	   own	   backbone	   amide	   is	  
highlighted	  in	  red	  dots,	  and	  indicated	  by	  an	  arrowhead.	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Figure	  7	  Cardiolipin	  binding	  site	  of	  the	  yeast	  ADP/ATP	  carrier.	  (A)	  Different	  views	  of	  
the	   three	   cardiolipin-­‐binding	   sites	   of	   Aac2p	   [67].	   The	   protein	   and	   cardiolipin	  
molecules	   are	   shown	   in	   wheat	   cartoon	   and	   CPK	   ball-­‐and-­‐stick	   representations,	  
respectively.	   The	   cardiolipin	   acyl	   chains	   have	   only	   been	   partially	   modelled.	   (B)	  
Detailed	   view	   of	   the	   binding	   site	   for	   cardiolipin.	   The	   carrier	   is	   shown	   in	   wheat	  
cartoon	  representation.	  Hydrogen	  bonds	  within	  the	  helices	  are	  shown	  as	  thin	  black	  
dotted	  lines.	  Residues	  in	  the	  [YWF][KR]G	  and	  [YF]XG	  motifs	  are	  shown	  in	  violet	  and	  
green,	  respectively.	  Hydrogen	  bond	  interactions	  between	  protein	  and	  cardiolipin	  are	  
shown	  as	  thick	  cyan	  dashed	  lines.	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Figure	   8	   Yeast	   ADP/ATP	   carriers	   in	   the	   membrane	   –	   molecular	   dynamics	  
simulations	   and	   atomic	   force	   microscopy.	   	   A	   Cytoplasmic	   and	   B	   lateral	   view	   of	  
Aac2p	  in	  a	  dioleoylphosphatidylcholine	  bilayer	  (orange	  stick	  representation).	  Aac2p	  
and	   cardiolipin	   molecules	   are	   shown	   in	   CPK	   and	   orange	   sphere	   representations,	  
respectively.	  Aac2p	  [67]	  and	  cardiolipin	  molecules	  complete	  with	  oleoyl	  chains	  were	  
equilibrated	   and	   simulated	   for	   2	   ns.	   C	   High-­‐resolution	   atomic	   force	   microscopy	  
topograph	  of	  a	  two	  dimensional	  crystal	   (similar	  to	  Figure	  2).	  Because	  of	  the	  crystal	  
symmetry,	   the	   crystal	   in	  a	  dioleoyl	  phosphocholine	  bilayer	   contains	   rows	  of	  Aac3p	  
crystallographic	  dimers	  with	  matrix	  side	  up	  or	  down	  orientations	  [74].	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Figure	  9	  Different	  approaches	  used	  for	  identification	  of	  the	  substrate	  binding	  site.	  
The	   substrate	   binding	   site	   of	   AAC1	   identified	   by	   (A)	   chemical	   and	   distance	  
constraints	   [90,	   91],	   by	   (B)	   symmetry	   analysis	   [92],	   and	   by	   (C)	   and	   (D)	   molecular	  
dynamics	  simulations	  [87,	  89,	  93].	  The	  key	  residues	  are	  shown	  as	  red	  sticks,	  except	  
for	  (B),	  where	  the	  sticks	  are	  coloured	  according	  to	  their	  symmetry	  score	  from	  highly	  
asymmetric	  (red)	  to	  neutral	  (white)	  to	  highly	  symmetric	  (blue).	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Figure	   10	   Putative	   substrate	   binding	   site	   of	   the	   mitochondrial	   ADP/ATP	   carrier.	  
Proposed	   pose	   of	   ATP	   on	   the	   substrate	   binding	   site	   of	   the	   yeast	   ADP/ATP	   carrier	  
Aac2p	  [67],	  shown	  (A)	  above	  from	  the	   intermembrane	  space	  and	  (B)	   laterally	   from	  
the	   membrane.	   The	   ATP	   is	   shown	   in	   yellow	   stick	   representation,	   whereas	   the	  
residues	   of	   the	   binding	   site	   are	   shown	   in	   green	   ball-­‐and-­‐stick	   representation.	  
Indicated	  by	  roman	  numerals	  are	  the	  contact	  points	  of	  the	  binding	  site	  [90,	  91].	  ATP	  
has	   four	   negative	   charges,	  whereas	   the	   substrate	   binding	   site	   has	   three	   positively	  
charged	  residues,	  leaving	  a	  net	  charge	  of	  minus	  one.	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Figure	  11	  Main	  functional	  elements	  of	  the	  mitochondrial	  ADP/ATP	  carrier.	  	  Lateral	  
view	   of	   the	   yeast	   Aac2p	   [67]	   in	   cartoon	   representation,	   showing	   the	   central	  
substrate	   binding	   site	   (stick),	   the	   cytoplasmic	   salt	   bridge	   network	   (top,	   ball	   and	  
stick),	  and	  the	  matrix	  salt	  bridge	  network	  (bottom,	  ball	  and	  stick).	  Positively	  charged,	  
negatively	   charged	   and	   polar	   residues	   are	   shown	   in	   blue,	   red,	   and	   green,	  
respectively.	  Also	  shown	  are	  the	  two	  networks	  in	  schematic	  representations.	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Figure	   12	   Proposed	   transport	  mechanism	   of	   the	  mitochondrial	   ADP/ATP	   carrier.	  
Transport	   cycle	   of	   strict	   equimolar	   ADP-­‐ATP	   exchange.	   Negatively	   charged	   and	  
positively	   charged	   residues	  of	   the	   salt	  bridge	  networks	  are	   shown	  as	   red	  and	  blue	  
sticks,	   respectively.	   The	   imported	   ADP	   and	   exported	   ATP	   are	   green	   and	   cyan,	  
respectively.	  The	  hexagon	  indicates	  the	  position	  of	  the	  asymmetric	  substrate	  binding	  
site.	   All	   transport	   steps	   are	   fully	   reversible,	   but	   the	   direction	   of	   transport	   (black	  
arrow	   heads)	   is	   determined	   by	   the	   membrane	   potential	   and	   by	   the	   chemical	  
gradients	  of	  ADP	  and	  ATP.	  During	  substrate	  import,	  the	  matrix	  network	  on	  the	  odd-­‐
numbered	   α-­‐helices	   is	   released	   whilst	   the	   cytoplasmic	   network	   on	   the	   even-­‐
numbered	  α-­‐helices	  is	  formed,	  and	  the	  converse	  is	  true	  during	  substrate	  export.	  The	  
structural	   changes	   might	   occur	   via	   a	   simultaneous	   twist	   of	   the	   three	   domains	  
(orange	  arrows).	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Figure	  13	  Thermostability	  of	  purified	  wild-­‐type	  ADP/ATP	  carrier	  of	  Myceliophthora	  
thermophile	   in	   detergent	   in	   the	   presence	   of	   inhibitors	   and	   ADP.	   A	   The	  
thermostability	  assay	  uses	  the	  probe	  CPM,	  which	  reacts	  with	  exposed	  protein	  thiols	  
to	  form	  a	  blue	  fluorescent	  adduct	  [97].	  In	  the	  procedure,	  the	  temperature	  of	  purified	  
protein	  samples	   is	   increased	  from	  25	  to	  90	  °C	  while	  protein	  unfolding	  is	  monitored	  
with	   CPM,	   as	   buried	   cysteine	   residues	   become	   solvent	   exposed	   due	   to	   thermal	  
denaturation	  of	  the	  protein	  [98].	  B	  Representative	  unfolding	  profiles	  of	  uninhibited	  
AAC	  (black	   line),	  CATR-­‐inhibited	  AAC	  (blue	   line)	  and	  BKA-­‐inhibited	  AAC	  (red	   line)	   in	  
detergent	   [96].	   The	   substrate	   ADP	   was	   added	   to	   shift	   the	   entire	   population	   of	  
carriers	  to	  the	   inhibited	  conformations.	  C	  Derivatives	  of	  the	  unfolding	  profiles	   in	  B.	  



















Figure	   14	   Cytoplasmic	   salt	   bridge	   network	   of	   the	  mitochondrial	   ADP/ATP	   carrier	  
(A)	   View	   from	   the	   intermembrane	   space/cytoplasm	   of	   the	   comparative	   homology	  
model	  of	   the	  ADP/ATP	  carrier	  of	  Myceliophthora	  thermophile	  based	  on	  the	  related	  
structure	  of	  Aac2p	  of	  Saccharomyces	   cerevisiae	   (4C9G)[67].	  Acidic,	   basic	   and	  polar	  
residues	   are	   shown	   as	   red,	   blue	   and	   green	   sticks,	   respectively.	   Schematic	  
representations	  of	   the	  cytoplasmic	  salt	  bridge	  network	  of	   (B)	   the	  wild-­‐type	  and	  (C)	  
the	   cytoplasmic	   network	  mutants.	   The	   semi-­‐quantitative	   interaction	   energy	   of	   the	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cytoplasmic	  network	  is	  indicated	  in	  the	  centre,	  in	  which	  1	  and	  0.5	  point	  are	  assigned	  





Figure	  15	  Thermostability	  of	  the	  BKA-­‐inhibited	  conformation	  is	  dependent	  on	  the	  
interaction	  energy	  of	   the	  cytoplasmic	  network.	  Apparent	  melting	  temperatures	  of	  
wildtype	  and	  mutant	  were	  determined	   in	   the	  absence	  of	   inhibitor	   (black)	  or	   in	   the	  
presence	   of	   CATR	  plus	  ADP	   (blue)	   or	   BKA	  plus	  ADP	   (red)	   [96].	   The	   double	  mutant	  
with	   an	   interaction	   energy	   of	   0.5	   could	   not	   be	   locked	   in	   the	   BKA-­‐inhibited	  matrix	  
conformation.	   The	   theoretical	   interaction	   energy	   is	   shown	   between	   brackets	   (see	  
legend	  to	  Fig.	  1).	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Figure	  16	  Conserved	  properties	  of	   the	   inter-­‐domain	   interfaces	   suggest	  a	  domain-­‐
based	   mechanism	   of	   transport.	   The	   structure	   of	   the	   yeast	   ADP/ATP	   carrier	   in	  
cartoon	  representation	  viewed	   from	  the	  cytoplasmic	  side	   [67].	   	  Domain	  1,	  2	  and	  3	  
are	  coloured	  blue,	  yellow,	  and	  red,	  respectively.	  (A)	  Residues	  of	  the	  odd-­‐numbered	  
α-­‐helices	   in	   the	   inter-­‐domain	   interface	   have	   no	   or	   small	   side	   chains,	   including	   the	  
residues	   of	   the	   conserved	   GXXXG	   motif.	   (B)	   Residues	   of	   the	   even-­‐numbered	   α-­‐
helices	   in	  the	   inter-­‐domain	   interface	  are	  mostly	  either	  hydrophobic	  (brown),	   facing	  
the	   membrane,	   or	   hydrophilic	   (blue),	   facing	   the	   cavity.	   (C)	   Proposed	   schematic	  
domain	   motions	   in	   the	   transport	   cycle	   [67].	   The	   grey	   lines	   represent	   the	   helical	  
arrangement	  in	  the	  cytoplasmic	  conformation,	  whereas	  the	  coloured	  lines	  represent	  
the	   helical	   arrangement	   in	   the	   matrix	   conformation.	   The	   positive	   and	   negatively	  
charged	  residues	  of	  the	  cytoplasmic	  salt	  bridge	  network	  are	  shown	  in	  blue	  and	  red,	  
respectively.	   The	   formation	   of	   the	   cytoplasmic	   salt	   bridge	   network	   is	   shown	   as	  
dashed	  lines.	  
